In human breast cancer cells in vitro, estradiol is a potent inhibitor of HER2 expression and sHER2 shedding [41,42,43,44]; whereas, progesterone positively regulates HER2 expression [45]. This evidence concerns the gene ERBB2 and breast cancer.